Baricitinib manufacturers in China

Baricitinib is an oral inhibitor of JAK kinase 1 and 2 that commonly used in the treatment of moderate to severe active rheumatoid arthritis (RA) in adults.For rheumatoid arthritis patients who had not previously been treated with biodmards, barricotinib reduced disease activity We now have the most complete medical raw materials, pharmaceutical intermediates and organic intermediates and so on.We focus on the foreign market, the products are exported to the United States and other countries, such as the Netherlands, Poland, Canada, Britain, Italy, Colombia and so on.In addition, there are custom synthesis of various organic compounds as a complement to the business.Welcome new and old customers to consult and purchase, looking forward to cooperating with you!

　　Baricitinib is an orally administered inhibitor of JAK kinases 1 and 2 and is commonly used in the treatment of moderate to severe active rheumatoid arthritis (RA) in adults. For patients with rheumatoid arthritis who have not previously used bio-DMARDS drugs, barikantinib can reduce the disease activity.